Global prescription sales up 6.4%: IMS Health

Share this article:

According to an IMS Health report, global prescription sales topped $712 billion in 2007, a 6.4% growth.

The US remains the single largest market, at $286.5 billion, despite its “lowest-ever level” of contribution to global growth in 2007, at 25.5%.  Total prescription sales in the US grew 3.8%, according to the report.

Asian (excluding Japan, including Australia and New Zealand) and Latin American markets saw the most expansion last year, posting 13.3% and 11.6% growths respectively.  China grew by 25.7%.

In the US, lipid regulators for cholesterol were the top-selling therapeutic class, at $18.4 billion, while anti-depressants represented the largest therapeutic class by dispensed prescriptions, at 232.7 million, according to the IMS data.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.